Area of research
Oncology · Cancer Research
Research interest
Research focused on Aflibercept and Docetaxel, with related work in Colorectal cancer, Pharmaceutical care, Oxaliplatin. Notable publications include 'Hypersensitivity to oxaliplatin: clinical features and risk factors', 'Expression of young HERV-H loci in the course of colorectal carcinoma and correlation with molecular subtypes', and 'Phase I Dose-Escalation Study of Intravenous Aflibercept in Combination with Docetaxel in Patients with Advanced Solid Tumors'.
Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomised controlled trial, the PEPs fatigue study
Expression of young HERV-H loci in the course of colorectal carcinoma and correlation with molecular subtypes
EPICC study: evaluation of pharmaceutical intervention in cancer care
Hypersensitivity to oxaliplatin: clinical features and risk factors
Phase I Dose-Escalation Study of Intravenous Aflibercept in Combination with Docetaxel in Patients with Advanced Solid Tumors
Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours